| Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection HJ Delecluse, I Anagnostopoulos, F Dallenbach, M Hummel, T Marafioti, ... Blood, The Journal of the American Society of Hematology 89 (4), 1413-1420, 1997 | 987 | 1997 |
| Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells HJ Delecluse, T Hilsendegen, D Pich, R Zeidler, W Hammerschmidt Proceedings of the National Academy of Sciences 95 (14), 8245-8250, 1998 | 588 | 1998 |
| Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases SE Coupland, L Krause, HJ Delecluse, I Anagnostopoulos, HD Foss, ... Ophthalmology 105 (8), 1430-1441, 1998 | 517 | 1998 |
| The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators R Feederle, M Kost, M Baumann, A Janz, E Drouet, W Hammerschmidt, ... The EMBO journal, 2000 | 506 | 2000 |
| The viral and cellular microRNA targetome in lymphoblastoid cell lines RL Skalsky, DL Corcoran, E Gottwein, CL Frank, D Kang, M Hafner, ... PLoS pathogens 8 (1), e1002484, 2012 | 411 | 2012 |
| B‐cell proliferation and induction of early G1‐regulating proteins by Epstein‐Barr virus mutants conditional for EBNA2. B Kempkes, D Spitkovsky, P Jansen‐Dürr, JW Ellwart, E Kremmer, ... The EMBO journal 14 (1), 88-96, 1995 | 331 | 1995 |
| Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells CD Shannon-Lowe, B Neuhierl, G Baldwin, AB Rickinson, HJ Delecluse Proceedings of the National Academy of Sciences 103 (18), 7065-7070, 2006 | 289 | 2006 |
| Epstein‐Barr virus infection and human malignancies G Niedobitek, N Meru, HJ Delecluse International journal of experimental pathology 82 (3), 149-170, 2001 | 284 | 2001 |
| Reactivation of latent Epstein–Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas W Feng, JI Cohen, S Fischer, L Li, M Sneller, R Goldbach-Mansky, ... Journal of the National Cancer Institute 96 (22), 1691-1702, 2004 | 280 | 2004 |
| The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold S Humme, G Reisbach, R Feederle, HJ Delecluse, K Bousset, ... Proceedings of the National Academy of Sciences 100 (19), 10989-10994, 2003 | 270 | 2003 |
| Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas W Feng, G Hong, HJ Delecluse, SC Kenney Journal of virology 78 (4), 1893-1902, 2004 | 263 | 2004 |
| The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome PM Bhende, WT Seaman, HJ Delecluse, SC Kenney Nature genetics 36 (10), 1099-1104, 2004 | 262 | 2004 |
| Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model GK Hong, ML Gulley, WH Feng, HJ Delecluse, E Holley-Guthrie, ... Journal of virology 79 (22), 13993-14003, 2005 | 256 | 2005 |
| Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection O Chijioke, A Müller, R Feederle, MHM Barros, C Krieg, V Emmel, ... Cell reports 5 (6), 1489-1498, 2013 | 248 | 2013 |
| Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas MH Tsai, A Raykova, O Klinke, K Bernhardt, K Gärtner, CS Leung, ... Cell reports 5 (2), 458-470, 2013 | 243 | 2013 |
| Interleukin (IL)-10 and IL-6 Are Produced in Vivo by Non-Hodgkin's Lymphoma Cells and Act as Cooperative Growth Factors N Voorzanger, R Touitou, E Garcia, HJ Delecluse, F Rousset, I Joab, ... Cancer research 56 (23), 5499-5505, 1996 | 241 | 1996 |
| Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with … SJ Hamilton-Dutoit, D Rea, M Raphael, K Sandvej, HJ Delecluse, ... The American journal of pathology 143 (4), 1072, 1993 | 241 | 1993 |
| Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands A Janz, M Oezel, C Kurzeder, J Mautner, D Pich, M Kost, ... Journal of virology 74 (21), 10142-10152, 2000 | 239 | 2000 |
| Epstein–Barr virus-associated tumours: an update for the attention of the working pathologist HJ Delecluse, R Feederle, B O’Sullivan, P Taniere Journal of clinical pathology 60 (12), 1358-1364, 2007 | 208 | 2007 |
| Glycoprotein gp110 of Epstein–Barr virus determines viral tropism and efficiency of infection B Neuhierl, R Feederle, W Hammerschmidt, HJ Delecluse Proceedings of the National Academy of Sciences 99 (23), 15036-15041, 2002 | 202 | 2002 |
